Induction of BIM Is Essential for Apoptosis Triggered by EGFR Kinase Inhibitors in Mutant EGFR-Dependent Lung Adenocarcinomas

Documenti analoghi

• Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer
  di: Pao, William, et al.
  Pubblicazione: (2010)
• Development of new mouse lung tumor models expressing EGFR T790M mutants associated with clinical resistance to kinase inhibitors.
  di: Lucia Regales, et al.
  Pubblicazione: (2007-08-01)
• Development of New Mouse Lung Tumor Models Expressing EGFR T790M Mutants Associated with Clinical Resistance to Kinase Inhibitors
  di: Regales, Lucia, et al.
  Pubblicazione: (2007)
• Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain
  di: Pao, William, et al.
  Pubblicazione: (2005)
• Acquired Resistance to EGFR Kinase Inhibitors Associated with a Novel T854A Mutation in a Patient with EGFR-Mutant Lung Adenocarcinoma
  di: Bean, James, et al.
  Pubblicazione: (2008)